(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 22.47%369.7M | 26.82%695.95M | 13.77%301.86M | 18.20%548.75M | --265.32M | 68.18%464.28M | --276.06M |
Operating income | 22.47%369.7M | 26.82%695.95M | 13.77%301.86M | 18.20%548.75M | 265.32M | 68.18%464.28M | 276.06M |
Cost of sales | -26.96%-322.59M | -26.78%-608.31M | -10.49%-254.09M | -17.65%-479.81M | ---229.96M | -83.65%-407.84M | ---222.07M |
Operating expenses | -26.96%-322.59M | -26.78%-608.31M | -10.49%-254.09M | -17.65%-479.81M | -229.96M | -83.65%-407.84M | -222.07M |
Gross profit | -1.38%47.11M | 27.12%87.64M | 35.10%47.77M | 22.16%68.94M | 35.36M | 4.53%56.44M | 53.99M |
Selling expenses | -15.12%-3.64M | -60.11%-8.15M | -38.82%-3.16M | -42.61%-5.09M | ---2.28M | -34.00%-3.57M | ---2.66M |
Administrative expenses | -18.80%-20.96M | -19.41%-35.68M | -25.97%-17.65M | -34.42%-29.88M | ---14.01M | -143.29%-22.23M | ---9.14M |
Research and development expenses | 24.10%-6.68M | 5.70%-22.23M | 33.75%-8.81M | -38.48%-23.57M | ---13.29M | -61.07%-17.02M | ---10.57M |
Impairment and provision | -19.07%-2.34M | -793.55%-4.16M | -509.39%-1.96M | -507.89%-465K | --479K | 171.25%114K | ---160K |
-Other impairment is provision | -19.07%-2.34M | -793.55%-4.16M | -509.39%-1.96M | -507.89%-465K | --479K | 171.25%114K | ---160K |
Special items of operating profit | 486.77%4.3M | 1,296.59%1.23M | 2,614.81%733K | -97.33%88K | --27K | 4,232.89%3.29M | --76K |
Operating profit | 5.07%17.79M | 86.11%18.66M | 169.06%16.93M | -41.11%10.03M | 6.29M | -46.03%17.02M | 31.54M |
Financing cost | -58.03%-2.94M | -68.80%-3.99M | -70.27%-1.86M | -3.14%-2.36M | ---1.09M | -16.30%-2.29M | ---1.97M |
Earning before tax | -1.47%14.85M | 91.45%14.67M | 189.83%15.07M | -47.99%7.66M | 5.2M | -50.18%14.73M | 29.57M |
Tax | -22.39%-2.31M | -220.49%-447K | -892.11%-1.89M | 118.12%371K | ---190K | 51.08%-2.05M | ---4.19M |
After-tax profit from continuing operations | -4.88%12.54M | 77.05%14.22M | 163.19%13.19M | -36.67%8.03M | 5.01M | -50.03%12.69M | 25.39M |
Earning after tax | -4.88%12.54M | 77.05%14.22M | 163.19%13.19M | -36.67%8.03M | 5.01M | -50.03%12.69M | 25.39M |
Minority profit | -22.30%223K | --301K | --287K | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -4.49%12.32M | 73.30%13.92M | 157.47%12.9M | -36.67%8.03M | 5.01M | -50.03%12.69M | 25.39M |
Basic earnings per share | 0.00%0.03 | 0.03 | |||||
Diluted earnings per share | 0.00%0.03 | 0.03 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data